These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21766420)

  • 1. Clinical use of temporary percutaneous left ventricular assist devices.
    Froesch P; Martinelli M; Meier P; Cook S; Hullin R; Windecker S; Mohacsi P; Meier B
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):304-13. PubMed ID: 21766420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest.
    Bagai J; Webb D; Kasasbeh E; Crenshaw M; Salloum J; Chen J; Zhao D
    J Invasive Cardiol; 2011 Apr; 23(4):141-7. PubMed ID: 21474846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left ventricular support for high-risk PCI and cardiogenic shock: who gets what?
    Shah R; Thomson A; Atianzar K; Somma K; Mehra A; Clavijo L; Matthews RV; Shavelle DM
    Cardiovasc Revasc Med; 2012; 13(2):101-5. PubMed ID: 22406055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.
    Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E
    Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tools & techniques: Percutaneous left ventricular assist devices.
    Thiele H; Fürnau G; Fischer J; Schuler G
    EuroIntervention; 2011 Sep; 7(5):636-7. PubMed ID: 21930469
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support.
    Lamarche Y; Cheung A; Ignaszewski A; Higgins J; Kaan A; Griesdale DE; Moss R
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):60-5. PubMed ID: 20880553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population.
    Tempelhof MW; Klein L; Cotts WG; Benzuly KH; Davidson CJ; Meyers SN; McCarthy PM; Malaisrie CS; McGee EC; Beohar N
    ASAIO J; 2011; 57(4):254-61. PubMed ID: 21546824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-centre experience with the Thoratec paracorporeal ventricular assist device for patients with primary cardiac failure.
    Kirsch M; Vermes E; Damy T; Nakashima K; Sénéchal M; Boval B; Drouet L; Loisance D
    Arch Cardiovasc Dis; 2009; 102(6-7):509-18. PubMed ID: 19664570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock.
    Cyrus T; Mathews SJ; Lasala JM
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S1-6. PubMed ID: 20333708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.
    Thomas JL; Al-Ameri H; Economides C; Shareghi S; Abad DG; Mayeda G; Burstein S; Shavelle DM
    J Invasive Cardiol; 2010 Aug; 22(8):360-4. PubMed ID: 20679671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.